Bath & Body Works, Inc.

FRC's fair value estimate for Bath & Body Works, Inc., and the rating behind it. BBWI last traded at $21.38, 5.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Bath & Body Works, Inc.. Starting points for Bath & Body Works, Inc.: P/E 5.7, EPS $3.87, beta 1.40 — an Specialty Retail name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Bath & Body Works, Inc.. Bath & Body Works, Inc. paid $0.80 per share over the last year — a 3.7% yield at the current $21.38 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Bath & Body Works, Inc.. Trailing twelve-month EPS for Bath & Body Works, Inc. stands at $3.87. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Bath & Body Works, Inc.. Bath & Body Works, Inc. has reported as a listed company since 1982. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Bath & Body Works, Inc. valued side by side against its closest peers. Bath & Body Works, Inc. is measured against Specialty Retail peers within the Consumer Cyclical sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Bath & Body Works, Inc., and how their positions are changing. At a $4.31B market value, institutional positions materially move Bath & Body Works, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Bath & Body Works, Inc. executives and directors. Shares of Bath & Body Works, Inc. have traded between $20.86 and $41.87 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Bath & Body Works, Inc.. Bath & Body Works, Inc. is a $4.31B Consumer Cyclical company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Bath & Body Works, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Bath & Body Works, Inc.. Coverage tracks Bath & Body Works, Inc. within Specialty Retail (Consumer Cyclical). Press releases and market coverage, newest first.